# Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

> **NCT01653847** · NA · COMPLETED · sponsor: **Northwestern University** · enrollment: 88 (actual)

## Conditions studied

- End Stage Renal Failure With Renal Transplant

## Interventions

- **DRUG:** Tacrolimus with MMF
- **DRUG:** Group 2: Tacrolimus with Everolimus.

## Key facts

- **NCT ID:** NCT01653847
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2021-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653847, "Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01653847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*